MW-03

inhibits proliferation of colon cancer cells

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/2017 - "Although the target of MW-03 for cell cycle inhibition has not yet been identified, these dual anti-cancer effects of MW-03 itself and/or its leading compound(s) on colon cancer cells may reduce colon cancer development and, thus, have potential as a novel treatment for the early stage of this disease." 01/01/2017 - "Anti-cancer Effects of MW-03, a Novel Indole Compound, by Inducing 15-Hydroxyprostaglandin Dehydrogenase and Cellular Growth Inhibition in the LS174T Human Colon Cancer Cell Line."
2.	Colonic Neoplasms (Colon Cancer) 01/01/2017 - "MW-03 also inhibited colon cancer cell growth by arresting the cell cycle at the S phase. " 01/01/2017 - "Although the target of MW-03 for cell cycle inhibition has not yet been identified, these dual anti-cancer effects of MW-03 itself and/or its leading compound(s) on colon cancer cells may reduce colon cancer development and, thus, have potential as a novel treatment for the early stage of this disease." 01/01/2017 - "Anti-cancer Effects of MW-03, a Novel Indole Compound, by Inducing 15-Hydroxyprostaglandin Dehydrogenase and Cellular Growth Inhibition in the LS174T Human Colon Cancer Cell Line."

1.	15-hydroxyprostaglandin dehydrogenase
2.	indole